Dr. Ewa Ellis has a Ph. D. in Experimental Medicine from the Karolinska Institute where she works as the Director for the Liver Cell Laboratory at Division of Transplantation Surgery at the Department of Clinical Science, Intervention and Technology. Dr. Ellis is specialized in human hepatocyte isolation, hepatocyte cultures and hepatocyte transplantation.

Ongoing research projects includes: Hepatocyte transplantation for metabolic liver disease. Isolation of human hepatocytes from disease and neonatal livers. Large scale production of human liver spheroids. Large scale bioreactor cultures and proliferation of primary human hepatocytes. Cold storage of cells and tissue. Tracking transplanted hepatocytes using biomarkers, identifying diseases with high liver cell turnover. Protein augmentation by transfection of modified RNA. Rare metabolic liver diseases. Role of FGF19 in human liver and bile acid metabolism. Studies on bile acid and lipoprotein metabolism in humanized FRGN mice. Human chimerism. Liver regeneration in ALPPS.

Dr Ellis is 49 years old and she is the current president of the Cell Transplant and Regenerative Medicine Society and she has been a council member since 2011.